The encouraging results of late-phase clinical trials investigating psychedelic-assisted
psychotherapy suggests that US Food and Drug Administration approval and subsequent …

Background: Ketamine has been used in anesthesia, pain management, and major
depressive disorder. It has recently been studied in patients with post-traumatic stress …

Depression with comorbid posttraumatic stress disorder (PTSD) is associated with more
severe symptoms and a reduced response to traditional treatments. Although ketamine …

Background: Traditional treatments for post-traumatic stress disorder (PTSD) often show
limited success with high dropout. Ketamine, an N-methyl-D-aspartate antagonist known for …

EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person
represents a critical step forward in the field of psychedelic therapy. The book is a …

Background Posttraumatic stress disorder (PTSD) is a complex and heterogeneous mental
health condition that can develop after exposure to a traumatic event. Clinical trials have …

Background Evidence from animal and human studies suggests glutamatergic dysfunction
in posttraumatic stress disorder (PTSD). The purpose of this study was to investigate …

Objective: This pilot case series investigated the feasibility and efficacy of an eight-week
therapy program, combining nasally administered ketamine (0.5 mg/kg) with trauma-focused …

Illness requiring critical care can lead to the development of posttraumatic stress disorder
(PTSD), a complex mental health condition resulting from exposure to traumatic events. In …

Ketamine is being actively investigated as a rapid-acting treatment for many conditions with
a stress-related psychopathology, including post-traumatic stress disorder (PTSD). The …